Cargando…
CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor–Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional Regulation
Glycogen synthase kinase 3β (GSK3β) activity is regulated by dopamine D2 receptor signaling and can be inhibited by psychoactive drugs in a D2 receptor–dependent manner. However, GSK3β is ubiquitously expressed in the brain, and D2 receptor–expressing cells are distributed as a mosaic in multiple co...
Autores principales: | Khlghatyan, Jivan, Beaulieu, Jean-Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307679/ https://www.ncbi.nlm.nih.gov/pubmed/32584144 http://dx.doi.org/10.1089/crispr.2019.0075 |
Ejemplares similares
-
Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD
por: Yen, Yi-Chun, et al.
Publicado: (2015) -
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
por: Chatterjee, Dipashree, et al.
Publicado: (2022) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
por: Khlghatyan, Jivan, et al.
Publicado: (2018) -
The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)